Showing 1 - 18 of 18 results
The Medium Energy- X-ray Absorption Spectroscopy beamlines will provide access to XANES and EXAFS data from a bending magnet source, optimised for cutting-edge applications in biological, agricultural and environmental science in an energy range that is not currently available at the Australia Synchrotron.
The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.
ANSTO has released the Independent Safety Review of Building 23 - Nuclear medicine production facility.
Read about an ANSTO scientist and their work to prepare for a school project or interview.
Planning is now underway for a second repatriation project which is scheduled to take place in 2022. Find out more information.
Stay updated with the latest news and notifications impacting ANSTO's landmark research infrastructure in both Sydney and Melbourne.
See details of previously published customer updates from our Health products team.
ANSTO's Chief Nuclear Officer shares insights on the safe management of Australia's nuclear waste.
The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.
ANSTO is a highly regulated organisation. Our governance system and processes provide critical guidance to effectively manage ANSTO’s activities. This section outlines the processes and systems that are in place to provide assurance to Government, our stakeholders and the community that we are working within our regulated and mandated requirements.
On the 9th of December 2022, the Minister for Industry, Science and Technology provided his Statement of Expectations to ANSTO.
Young physicist in training to become a surrogate inspector for Comprehensive Nuclear Test Ban Treaty Organisation.
Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.
Phase contrast tomography shows great promise in early stages of study and is expected to be tested on first patients by 2020.
With enhanced submicron spatial resolution, speed and contrast, the Micro-Computed Tomography beamline opens a window on the micron-scale 3D structure of a wide range of samples relevant to many areas of science including life sciences, materials engineering, anthropology, palaeontology and geology. MCT will be able to undertake high-speed and high-throughput studies, as well as provide a range of phase-contrast imaging modalities.
Publications and resources from the Powder Diffraction beamline.